Transcarent to acquire accolade

San francisco & seattle--(business wire)-- #healthwayfinding--transcarent, the one place for health and care, and accolade (nasdaq:accd), a leader in health advocacy, expert medical opinions, and primary care, announced that they have entered into a definitive agreement under which transcarent will acquire accolade for $7.03 per share in cash, which represents a total equity value of approximately $621m. this strategic combination, which has been unanimously approved by the boards of directors of both companies, w.
ACCD Ratings Summary
ACCD Quant Ranking